BackStoke Therapeutics Overview
Stoke Therapeutics Inc

Stoke Therapeutics Target Price

Where could STOK trade next? Consensus target price: $51.

Get informed when a big investor buys or sells

+ Follow

Share Price

$32.14

Average Target Price

$51.0058.7% upside

2 analysts in the last 4 months

High: $58 | Low: $44

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-04Canaccord GenuitySumant Kulkarni$5880.5% upsideOpen
2026-07-13Goldman SachsKevin Strang$4436.9% upsideOpen
2026-02-23Wolfe Research$4024.5% upsideOpen
2026-02-05GuggenheimYatin Suneja$6086.7% upsideOpen
2026-01-12Wedbush$3612% upsideOpen
2026-01-05Canaccord Genuity$3612% upsideOpen
2026-01-05Loop Capital MarketsKeay Nakae$358.9% upsideOpen
2025-12-16H.C. WainwrightAndrew Fein$5055.6% upsideOpen
2025-12-15UBS$5055.6% upsideOpen
2025-11-05Canaccord Genuity$2812.9% downsideOpen
2025-10-10Needham$358.9% upsideOpen
2025-08-18BTIGThomas Shrader$2812.9% downsideOpen
2024-10-11Leerink PartnersMarc Goodman$1844% downsideOpen
2024-09-11H.C. WainwrightDebjit Chattopadhyay$358.9% upsideOpen
2024-05-07Canaccord GenuitySumant Kulkami$2037.8% downsideOpen
2024-03-26NeedhamJoseph Stringer$2231.5% downsideOpen
2024-03-26Canaccord GenuitySumant Kulkami$2134.7% downsideOpen
2022-11-14Needham$2522.2% downsideOpen
2021-04-26Credit SuisseJudah Frommer$5880.5% upsideOpen

Stoke Therapeutics (STOK) FAQ

The latest target price for STOK is $51. Investors often review this figure alongside Stoke Therapeutics's historical trend and sector peers before judging valuation or financial health.

Stoke Therapeutics trades near $32.14 while the consensus target sits at $51 (58.7% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting STOK's target price ($51), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Stoke Therapeutics's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.